Advances of Traditional Chinese Medicine Preclinical Mechanisms and Clinical Studies on Diabetic Peripheral Neuropathy

Overview

Journal Pharm Biol

Specialties Pharmacology
Pharmacy

Date 2024 Jul 1

PMID 38946248

Authors

Yuna Zhang

Xianglong Wu

Wenhui Yao

Yadong Ni

Xuansheng Ding

Affiliations

Soon will be listed here.

Abstract

Context: Diabetic peripheral neuropathy (DPN) results in an enormous burden and reduces the quality of life for patients. Considering there is no specific drug for the management of DPN, traditional Chinese medicine (TCM) has increasingly drawn attention of clinicians and researchers around the world due to its characteristics of multiple targets, active components, and exemplary safety.

Objective: To summarize the current status of TCM in the treatment of DPN and provide directions for novel drug development, the clinical effects and potential mechanisms of TCM used in treating DPN were comprehensively reviewed.

Methods: Existing evidence on TCM interventions for DPN was screened from databases such as PubMed, the Cochrane Neuromuscular Disease Group Specialized Register (CENTRAL), and the Chinese National Knowledge Infrastructure Database (CNKI). The focus was on summarizing and analyzing representative preclinical and clinical TCM studies published before 2023.

Results: This review identified the ameliorative effects of about 22 single herbal extracts, more than 30 herbal compound prescriptions, and four Chinese patent medicines on DPN in preclinical and clinical research. The latest advances in the mechanism highlight that TCM exerts its beneficial effects on DPN by inhibiting inflammation, oxidative stress and apoptosis, endoplasmic reticulum stress and improving mitochondrial function.

Conclusions: TCM has shown the power latent capacity in treating DPN. It is proposed that more large-scale and multi-center randomized controlled clinical trials and fundamental experiments should be conducted to further verify these findings.

Citing Articles

Network Pharmacology Combined With Metabolomics Reveals the Mechanism of Yangxuerongjin Pill Against Type 2 Diabetic Peripheral Neuropathy in Rats.

Jin R, Pei H, Yue F, Zhang X, Zhang Z, Xu Y Drug Des Devel Ther. 2025; 19():325-347.

PMID: 39834645 PMC: 11745066. DOI: 10.2147/DDDT.S473146.

Comparative efficacy and safety of Chinese patent medicines as an adjunctive therapy for diabetic peripheral neuropathy: systematic review and network meta-analysis of randomized controlled trials.

Wang Q, Xie H, Wang Z, Huang R, Xu M, Li Y Pharm Biol. 2024; 62(1):833-852.

PMID: 39497372 PMC: 11539401. DOI: 10.1080/13880209.2024.2422084.

Whether coagulation dysfunction influences the onset and progression of diabetic peripheral neuropathy: A multicenter study in middle-aged and aged patients with type 2 diabetes.

Xie J, Yu X, Chen L, Cheng Y, Li K, Song M CNS Neurosci Ther. 2024; 30(9):e70040.

PMID: 39258827 PMC: 11388410. DOI: 10.1111/cns.70040.

References

Ji H, Zhang X, Du Y, Liu H, Li S, Li L . Polydatin modulates inflammation by decreasing NF-κB activation and oxidative stress by increasing Gli1, Ptch1, SOD1 expression and ameliorates blood-brain barrier permeability for its neuroprotective effect in pMCAO rat brain. Brain Res Bull. 2011; 87(1):50-9. DOI: 10.1016/j.brainresbull.2011.09.021. View

Yang X, Liu F, Guo J, Yao W, Li Q, Liu T . Antioxidation and anti-inflammatory activity of Tang Bi Kang in rats with diabetic peripheral neuropathy. BMC Complement Altern Med. 2015; 15:66. PMC: 4417275. DOI: 10.1186/s12906-015-0600-0. View

Zhao T, Zhou Z, Zhao S, Wan H, Li H, Hou J . Vincamine as an agonist of G protein-coupled receptor 40 effectively ameliorates pulmonary fibrosis in mice. Phytomedicine. 2023; 118:154919. DOI: 10.1016/j.phymed.2023.154919. View

Law B, Mo J, Wong V . Autophagic effects of Chaihu (dried roots of Bupleurum Chinense DC or Bupleurum scorzoneraefolium WILD). Chin Med. 2014; 9:21. PMC: 4165614. DOI: 10.1186/1749-8546-9-21. View

Hosseini A, Razavi B, Banach M, Hosseinzadeh H . Quercetin and metabolic syndrome: A review. Phytother Res. 2021; 35(10):5352-5364. DOI: 10.1002/ptr.7144. View

Guo C, Huang Q, Wang Y, Yao Y, Li J, Chen J . Therapeutic application of natural products: NAD metabolism as potential target. Phytomedicine. 2023; 114:154768. DOI: 10.1016/j.phymed.2023.154768. View

. 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes-2024. Diabetes Care. 2023; 47(Suppl 1):S231-S243. PMC: 10725803. DOI: 10.2337/dc24-S012. View

Yuan Q, Zhang X, Wei W, Zhao J, Wu Y, Zhao S . Lycorine improves peripheral nerve function by promoting Schwann cell autophagy via AMPK pathway activation and MMP9 downregulation in diabetic peripheral neuropathy. Pharmacol Res. 2021; 175:105985. DOI: 10.1016/j.phrs.2021.105985. View

Ma J, Yu H, Liu J, Chen Y, Wang Q, Xiang L . Curcumin promotes nerve regeneration and functional recovery after sciatic nerve crush injury in diabetic rats. Neurosci Lett. 2015; 610:139-43. DOI: 10.1016/j.neulet.2015.11.005. View

10.

Afshinnia F, Reynolds E, Rajendiran T, Soni T, Byun J, Savelieff M . Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes. Ann Clin Transl Neurol. 2022; 9(9):1392-1404. PMC: 9463947. DOI: 10.1002/acn3.51639. View

11.

Qu L, Liang X, Gu B, Liu W . Quercetin alleviates high glucose-induced Schwann cell damage by autophagy. Neural Regen Res. 2014; 9(12):1195-203. PMC: 4146282. DOI: 10.4103/1673-5374.135328. View

12.

Asadi S, Gholami M, Siassi F, Qorbani M, Khamoshian K, Sotoudeh G . Nano curcumin supplementation reduced the severity of diabetic sensorimotor polyneuropathy in patients with type 2 diabetes mellitus: A randomized double-blind placebo- controlled clinical trial. Complement Ther Med. 2019; 43:253-260. DOI: 10.1016/j.ctim.2019.02.014. View

13.

Yin Y, Qu H, Yang Q, Fang Z, Gao R . Astragaloside IV alleviates Schwann cell injury in diabetic peripheral neuropathy by regulating microRNA-155-mediated autophagy. Phytomedicine. 2021; 92:153749. DOI: 10.1016/j.phymed.2021.153749. View

14.

Iqbal Z, Azmi S, Yadav R, Ferdousi M, Kumar M, Cuthbertson D . Diabetic Peripheral Neuropathy: Epidemiology, Diagnosis, and Pharmacotherapy. Clin Ther. 2018; 40(6):828-849. DOI: 10.1016/j.clinthera.2018.04.001. View

15.

Zhang K, Peng P, Huang J, Chen M, Liu F, Zhu C . Integrating plasma metabolomics and gut microbiome to reveal the mechanisms of Huangqi Guizhi Wuwu Decoction intervene diabetic peripheral neuropathy. J Ethnopharmacol. 2023; 319(Pt 3):117301. DOI: 10.1016/j.jep.2023.117301. View

16.

Rauf A, Olatunde A, Imran M, Alhumaydhi F, Aljohani A, Khan S . Honokiol: A review of its pharmacological potential and therapeutic insights. Phytomedicine. 2021; 90:153647. DOI: 10.1016/j.phymed.2021.153647. View

17.

Geisler S, Holmstrom K, Treis A, Skujat D, Weber S, Fiesel F . The PINK1/Parkin-mediated mitophagy is compromised by PD-associated mutations. Autophagy. 2010; 6(7):871-8. DOI: 10.4161/auto.6.7.13286. View

18.

cizmarova B, Hubkova B, Tomeckova V, Birkova A . Flavonoids as Promising Natural Compounds in the Prevention and Treatment of Selected Skin Diseases. Int J Mol Sci. 2023; 24(7). PMC: 10094312. DOI: 10.3390/ijms24076324. View

19.

Lin Y, Chen H, Ko C, Chan M . Neuroprotective activity of honokiol and magnolol in cerebellar granule cell damage. Eur J Pharmacol. 2006; 537(1-3):64-9. DOI: 10.1016/j.ejphar.2006.03.035. View

20.

Gong X, Gui Z, Ye X, Li X . Jatrorrhizine ameliorates Schwann cell myelination via inhibiting HDAC3 ability to recruit Atxn2l for regulating the NRG1-ErbB2-PI3K-AKT pathway in diabetic peripheral neuropathy mice. Phytother Res. 2022; 37(2):645-657. DOI: 10.1002/ptr.7641. View